Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.

Uterine leiomyomas (uterine fibroids) arise from smooth muscle tissue in the majority of women by age 45. It is common for these clonal tumors to develop from multiple locations within the uterus, leading to a variety of symptoms such as pelvic pain, abnormal uterine bleeding, and infertility. We pe...

Full description

Bibliographic Details
Main Authors: Megan M McGuire, Alexander Yatsenko, Lori Hoffner, Mirka Jones, Urvashi Surti, Aleksandar Rajkovic
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3299761?pdf=render
id doaj-c90e0f83c4db4b31a0e17a6d7110ba0b
record_format Article
spelling doaj-c90e0f83c4db4b31a0e17a6d7110ba0b2020-11-24T21:33:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3325110.1371/journal.pone.0033251Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.Megan M McGuireAlexander YatsenkoLori HoffnerMirka JonesUrvashi SurtiAleksandar RajkovicUterine leiomyomas (uterine fibroids) arise from smooth muscle tissue in the majority of women by age 45. It is common for these clonal tumors to develop from multiple locations within the uterus, leading to a variety of symptoms such as pelvic pain, abnormal uterine bleeding, and infertility. We performed whole exome sequencing on genomic DNA from five pairs of leiomyomas and corresponding normal myometrium to determine genetic variations unique to leiomyomas. Whole exome sequencing revealed that the gene encoding transcription factor MED12 (Mediator complex subunit 12) harbored heterozygous missense mutations caused by single nucleotide variants in highly conserved codon 44 of exon 2 in two of five leiomyomas. Sanger re-sequencing of MED12 among these five leiomyomas confirmed the two single nucleotide variants and detected a 42 base-pair deletion within exon 2 of MED12 in a third leiomyoma. MED12 was sequenced in an additional 143 leiomyomas and 73 normal myometrial tissues. Overall, MED12 was mutated in 100/148 (67%) of the genotyped leiomyomas: 79/148 (53%) leiomyomas exhibited heterozygous missense single nucleotide variants, 17/148 (11%) leiomyomas exhibited heterozygous in-frame deletions/insertion-deletions, 2/148 (1%) leiomyomas exhibited intronic heterozygous single nucleotide variants affecting splicing, and 2/148 (1%) leiomyomas exhibited heterozygous deletions/insertion-deletions spanning the intron 1-exon 2 boundary which affected the splice acceptor site. Mutations were not detected in MED12 in normal myometrial tissue. MED12 mutations were equally distributed among karyotypically normal and abnormal uterine leiomyomas and were identified in leiomyomas from both black and white American women. Our studies show an association between MED12 mutations and leiomyomas in ethnically and racially diverse American women.http://europepmc.org/articles/PMC3299761?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Megan M McGuire
Alexander Yatsenko
Lori Hoffner
Mirka Jones
Urvashi Surti
Aleksandar Rajkovic
spellingShingle Megan M McGuire
Alexander Yatsenko
Lori Hoffner
Mirka Jones
Urvashi Surti
Aleksandar Rajkovic
Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
PLoS ONE
author_facet Megan M McGuire
Alexander Yatsenko
Lori Hoffner
Mirka Jones
Urvashi Surti
Aleksandar Rajkovic
author_sort Megan M McGuire
title Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
title_short Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
title_full Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
title_fullStr Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
title_full_unstemmed Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
title_sort whole exome sequencing in a random sample of north american women with leiomyomas identifies med12 mutations in majority of uterine leiomyomas.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Uterine leiomyomas (uterine fibroids) arise from smooth muscle tissue in the majority of women by age 45. It is common for these clonal tumors to develop from multiple locations within the uterus, leading to a variety of symptoms such as pelvic pain, abnormal uterine bleeding, and infertility. We performed whole exome sequencing on genomic DNA from five pairs of leiomyomas and corresponding normal myometrium to determine genetic variations unique to leiomyomas. Whole exome sequencing revealed that the gene encoding transcription factor MED12 (Mediator complex subunit 12) harbored heterozygous missense mutations caused by single nucleotide variants in highly conserved codon 44 of exon 2 in two of five leiomyomas. Sanger re-sequencing of MED12 among these five leiomyomas confirmed the two single nucleotide variants and detected a 42 base-pair deletion within exon 2 of MED12 in a third leiomyoma. MED12 was sequenced in an additional 143 leiomyomas and 73 normal myometrial tissues. Overall, MED12 was mutated in 100/148 (67%) of the genotyped leiomyomas: 79/148 (53%) leiomyomas exhibited heterozygous missense single nucleotide variants, 17/148 (11%) leiomyomas exhibited heterozygous in-frame deletions/insertion-deletions, 2/148 (1%) leiomyomas exhibited intronic heterozygous single nucleotide variants affecting splicing, and 2/148 (1%) leiomyomas exhibited heterozygous deletions/insertion-deletions spanning the intron 1-exon 2 boundary which affected the splice acceptor site. Mutations were not detected in MED12 in normal myometrial tissue. MED12 mutations were equally distributed among karyotypically normal and abnormal uterine leiomyomas and were identified in leiomyomas from both black and white American women. Our studies show an association between MED12 mutations and leiomyomas in ethnically and racially diverse American women.
url http://europepmc.org/articles/PMC3299761?pdf=render
work_keys_str_mv AT meganmmcguire wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
AT alexanderyatsenko wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
AT lorihoffner wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
AT mirkajones wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
AT urvashisurti wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
AT aleksandarrajkovic wholeexomesequencinginarandomsampleofnorthamericanwomenwithleiomyomasidentifiesmed12mutationsinmajorityofuterineleiomyomas
_version_ 1725954682586660864